J Neurogastroenterol Motil.
2024 Oct;30(4):480-490. 10.5056/jnm23161.
Clinicians’ Knowledge, Attitudes, and Practices Regarding the Management of Functional Gastrointestinal Disorders With Neuromodulators and Psychological Treatment
- Affiliations
-
- 1Chung-Ang University College of Medicine, Department of Internal Medicine, Seoul, Korea
- 2Department of Internal Medicine, Keimyung University School of Medicine, Daegu, Korea
- 3Catholic Kwandong University International St. Mary’s Hospital, Incheon, Korea
- 4Department of Psychiatry, Wonkwang University School of Medicine, Iksan, Jeonbuk-do, Korea
- 5Department of Internal Medicine, Wonkwang University School of Medicine, Iksan, Jeonbuk-do, Korea
- 6Department of Internal Medicine, Korea University Ansan Hospital, Ansan, Gyeonggi-do, Korea
- 7Korean Physicians’ Association
- 8The Korean Society of Digestive Endoscopy
- 9Department of Applied Statistics, Chung-Ang University, Seoul, Korea
- 10Digestive Disease Research Institute, Wonkwang University School of Medicine, Iksan, Jeonbuk-do, Korea
- 11Department of Internal Medicine, Daegu Catholic University School of Medicine, Daegu, Korea; Brain–Gut Axis Research Group of the Korean Society for Neurogastroenterology and Motility
- KMID: 2563193
- DOI: http://doi.org/10.5056/jnm23161
Abstract
- Background/Aims
Little is known about the practical clinical application of neuromodulators and psychiatric treatments in patients with functional gastrointestinal disorders (FGIDs). We investigate the knowledge, attitudes, and practices of Korean clinicians regarding the use of neuromodulators and psychiatric treatments for FGIDs.
Methods
This prospective, online, cross-sectional study was conducted between May and August 2022. A questionnaire regarding the knowledge, attitude, and practice of neuromodulators and psychiatric treatments for FGIDs was developed and administered to primary care clinicians and gastroenterologists in university hospitals in Korea.
Results
Overall, 451 clinicians from primary (n = 179, 39.7%), secondary (n = 113, 25.1%), and tertiary (n = 159, 35.3%) hospitals participated in the survey. Most of them considered that neuromodulators (98.7%) and psychiatric treatment (86.5%) were required for patients with FGIDs. However, approximately one-third of them did not prescribe neuromodulators, mainly due to unfamiliarity with the drugs, and only one-quarter considered psychiatric referral. Compared to gastroenterologists at university hospitals, primary care clinicians’ prescriptions had a lower rate (87.2% vs 64.2%, P < 0.001) and shorter duration of neuromodulator. The psychiatric referral rate was lower for primary care clinicians than for gastroenterologists at university hospitals (19.0% vs 34.2%, P < 0.001).
Conclusions
Knowledge, attitude, and practice levels regarding neuromodulators and psychiatric treatment among clinicians are inhomogeneous, and a knowledge gap exists between primary care clinicians and gastroenterologists at university hospitals. Encouraging ongoing education for Korean clinicians regarding the appropriate use of neuromodulators and psychiatric treatments in patients with FGIDs is suggested.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Clinicians’ Knowledge, Attitudes, and Practices Towards Neuromodulators and Psychological Treatment in Functional Gastrointestinal Disorders - Do They Know?
- Knowledge, Attitudes, and Practices of Infection Prevention in Mothers of Young Children
- How to Perform and Interpret Functional Magnetic Resonance Imaging Studies in Functional Gastrointestinal Disorders
- Cultural Factors Influencing Functional Gastrointestinal Disorders in the East
- Factors Related to Dementia Attitudes Among Dementia Care Providers: A Systematic Review and Meta-Analysis
